The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis

Mahmud, Sultan; Maqbool, Mohsin; Hossain, Sorif; Islam, Md. Mynul; Muyeed, Abdul

doi:10.1016/j.heliyon.2022.e10728

Cited by 16 publications

(17 citation statements)

References 116 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…vaccination. [19][20][21] Due to limited evidence because of the lack of long-term clinical outcomes, the acceptance of COVID-19 vaccination can vary according to cultural or regional differences.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 Dashboard, Release 2

Kwon¹,

Rahmati²

2022

Life Cycle

View full text Add to dashboard Cite

Objective: We aimed to better understand the impact of the COVID-19 pandemic through analysis of disruptions in a global, regional, and national status of COVID-19 vaccination coverage compared by a global scale, World Health Organization regions, World Bank income groups, and each country.Methods: Global datasets of 237 countries and territories from the World Health Organization Dashboard until March 5, 2022 were used and paired with estimates of COVID-19 vaccination coverage of individual levels which were derived from country level models form World Health Organization Dashboard, Release 1. The numbers of persons vaccinated with at least one dose, persons vaccinated with at least one dose per 100 population, and persons fully vaccinated per 100 population were then calculated and estimated. The data were described by a global scale and stratified by World Health Organization regions (Eastern Mediterranean, Americas, Europe, Southeast Asia, the Western Pacific, and Africa), World Bank income groups (high, upper-middle, lower-middle, and low income), and each country.Results: A total of 4,964,626,775 persons worldwide were vaccinated with at least one dose, which is 63.69 per 100 population administered of COVID-19 vaccines at least one dose, and 56.16 per 100 population were fully vaccinated. The number of persons vaccinated with at least one dose was highest in the Eastern Mediterranean (84.18 per 100 population), followed by the Americas (75.82 per 100 population), South-East Asia (68.97 per 100 population), Europe (66.28 per 100 population), Western Pacific (47.18 per 100 population), and Africa (15.87 per 100 population). Persons fully vaccinated had similar patterns of those vaccinated with at least one dose; Eastern Mediterranean (84.25 per 100 population), the Americas (65.08 per 100 population), Europe (61.59 per 100 population), South-East Asia (55.67 per 100 population), Western Pacific (39.04 per 100 population), and Africa (11.62 per 100 population). The proportion of persons who were vaccinated at least one dose or fully vaccinated was greatest in the high income countries, followed by upper-middle, lower-middle, and low income. Conclusion:The rate of COVID-19 vaccination with at least one dose and those who were fully vaccinated was estimated to be 63.69 per 100 population and 56.16 per 100 population, respectively. Although the COVID-19 vaccine coverage trajectories points towards global increasement in vaccination, persistent inequality in preventing the COVID-19 pandemic occurred in vulnerable groups such as under-developed and low income countries.

show abstract

Section: Discussionmentioning

confidence: 99%

“…A meta-analysis demonstrated that the COVID-19 vaccine acceptance rate was approximately 62.79% (95% confidence intervals [CI], 58.98 to 66.60). [19] According to regions, South-East Asia showed a vaccine acceptance rate as high as 70.18% (95% CI, 58.12 to 82.25), while…”

Section: Discussionmentioning

confidence: 99%

Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 Dashboard, Release 2

Kwon¹,

Rahmati²

2022

Life Cycle

View full text Add to dashboard Cite

show abstract

“…The PRISMA statement and the MOOSE checklist [ [53] , [54] , [55] ] were followed in this systematic review and meta-analysis. The protocol of the review was not registered previously.…”

Section: Methodsmentioning

confidence: 99%

“…Firstly, the overall pooled prevalence along with 95% CI and heterogeneity statistics was estimated from the summary of the meta-analysis. The between-study heterogeneity for the selected studies was assessed using the Q-test and I 2 statistics with a 5% level of significance [ 55 , 56 ]. Then, we applied a random effect model to estimate the pooled prevalence of HIV, syphilis, and their co-infection with 95% confidence intervals and the relative weight for each study.…”

Section: Methodsmentioning

confidence: 99%

Prevalence of HIV and syphilis and their co-infection among men having sex with men in Asia: A systematic review and meta-analysis

Mahmud

Maqbool

Muyeed

et al. 2023

Heliyon

Self Cite

View full text Add to dashboard Cite

“…79 Because the success of vaccination programs depends largely on the public's willingness to accept the vaccine, many studies have reported vaccine acceptance and hesitancy rates in various countries. 80 , 81 Furthermore, several research groups have aimed to assess the determinants of, and factors driving, vaccine hesitancy and acceptance. 82 , 83 Notably, many COVID-19 vaccine-associated studies have focused on healthcare workers (HCWs) in the early stages of the pandemic, because many countries prioritized vaccination of HCWs at the frontline of the pandemic response, who helped safeguard the lives of vulnerable populations.…”

Section: Vaccine Development Against Covid-19mentioning

confidence: 99%

Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection

Al-Hatamleh

Abusalah

Hatmal

et al. 2023

Journal of Taibah University Medical Sciences

View full text Add to dashboard Cite

The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis

Cited by 16 publications

References 116 publications

Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 Dashboard, Release 2

Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 Dashboard, Release 2

Prevalence of HIV and syphilis and their co-infection among men having sex with men in Asia: A systematic review and meta-analysis

Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection

Contact Info

Product

Resources

About